Relay Therapeutics, Inc. (RLAY) has a market capitalization of $2.64B and trades at $14.75. The 52-week range is 1.775-13.04.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -9.2, Earnings Per Share (EPS) of $-1.61, annual revenue of $15.36M.
The stock has a beta of 1.58, operates in the Healthcare sector.
